Literature DB >> 20381598

Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery.

Jianing Qi1, Ping Yao, Fen He, Chuiliang Yu, Chong Huang.   

Abstract

Biocompatible bovine serum albumin (BSA)-dextran-chitosan nanoparticles were fabricated by heating the mixture of chitosan and BSA-dextran conjugates by virtue of the electrostatic attraction between BSA and chitosan as well as the gelation of BSA. The BSA-dextran conjugates were prepared by Maillard reaction. The nanoparticles were characterized by light scattering, zeta-potential, atomic force microscopy and pyrene fluorescence. The nanoparticles having a spherical shape and hydrodynamic diameters of 130-230 nm are stable in physiological condition. Doxorubicin can be effectively loaded into the nanoparticles after changing the pH of their mixture to 7.4 by virtue of the electrostatic and hydrophobic interactions between the nanoparticles and doxorubicin. The antitumor effects of doxorubicin loaded nanoparticles were investigated by the tumor inhibition and survivability of murine ascites hepatoma H22 tumor-bearing mice. The loaded nanoparticles can largely decrease the toxicity of doxorubicin and significantly increase the survivability of the tumor-bearing mice. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381598     DOI: 10.1016/j.ijpharm.2010.03.063

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  25 in total

1.  Development of oxaliplatin encapsulated in magnetic nanocarriers of pectin as a potential targeted drug delivery for cancer therapy.

Authors:  Raj Kumar Dutta; Saurabh Sahu
Journal:  Results Pharma Sci       Date:  2012-05-22

2.  A Novel Thermal-driven Self-assembly Method to Prepare Albumin Nanoparticles: Formation Kinetics, Degradation Behavior and Formation Mechanism.

Authors:  Fang Li; Stacy Yeh; Qin Shi; Peng Wang; Hongyan Wu; Junbo Xin
Journal:  AAPS PharmSciTech       Date:  2022-09-07       Impact factor: 4.026

Review 3.  Deciphering albumin-directed drug delivery by imaging.

Authors:  Huiyu Hu; Jeremy Quintana; Ralph Weissleder; Sareh Parangi; Miles Miller
Journal:  Adv Drug Deliv Rev       Date:  2022-03-29       Impact factor: 17.873

4.  Cellular Uptake and Intracellular Cargo Release From Dextran Based Nanogel Drug Carriers.

Authors:  M Carme Coll Ferrer; Peter Sobolewski; Russell J Composto; David M Eckmann
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

Review 5.  Harnessing albumin as a carrier for cancer therapies.

Authors:  Ella N Hoogenboezem; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2018-07-27       Impact factor: 15.470

6.  Probing the binding sites of antibiotic drugs doxorubicin and N-(trifluoroacetyl) doxorubicin with human and bovine serum albumins.

Authors:  Daniel Agudelo; Philippe Bourassa; Julie Bruneau; Gervais Bérubé; Eric Asselin; Heidar-Ali Tajmir-Riahi
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  A review on composite liposomal technologies for specialized drug delivery.

Authors:  Maluta S Mufamadi; Viness Pillay; Yahya E Choonara; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo
Journal:  J Drug Deliv       Date:  2011-02-08

8.  Chitosan, Polyethylene Glycol and Polyvinyl Alcohol Modified MgFe2O4 Ferrite Magnetic Nanoparticles in Doxorubicin Delivery: A Comparative Study In Vitro.

Authors:  Deevak Ramnandan; Seipati Mokhosi; Aliscia Daniels; Moganavelli Singh
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

9.  Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA.

Authors:  Haliza Katas; Maria Abdul Ghafoor Raja; Kai Leong Lam
Journal:  Int J Biomater       Date:  2013-09-30

10.  Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.

Authors:  Fang Li; Chunli Zheng; Junbo Xin; Fangcheng Chen; Hua Ling; Linlin Sun; Thomas J Webster; Xin Ming; Jianping Liu
Journal:  Int J Nanomedicine       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.